A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel
- Conditions
- ColitisGastroenteritisInfectious
- Registration Number
- NCT01326013
- Lead Sponsor
- Luminex Molecular Diagnostics
- Brief Summary
The xTAG Gastrointestinal Pathogen Panel (xTAG GPP) is a PCR-based assay to detect the presence or absence of gastrointestinal (GI) pathogens from human stool specimens.
The objective of this study is to establish diagnostic accuracy of the xTAG GPP.
- Detailed Description
The xTAG GPP assay is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify bacterial (and toxins), viral, and parasitic pathogens extracted from human stool specimens collected from patients with signs and symptoms of infectious colitis or gastroenteritis.
The objective of this study is to establish the diagnostic accuracy of xTAG GPP through a multi-site, method comparison study on prospectively collected, left-over, and anonymized stool specimens. The prospective sample set will also be supplemented with pre-selected archived left-over specimens (for low prevalence targets only). Diagnostic accuracy will be expressed in terms of clinical sensitivity and specificity for each target.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1534
- The specimen is stool.
- The specimen is from a pediatric or adult, male or female subject who is either hospitalized, admitted to a hospital emergency department, visiting an outpatient clinic or resident of a long-term care facility.
- The specimen is from a patient exhibiting clinical signs and symptoms of infectious colitis or gastroenteritis.
- The specimen is a preserved stool, stool in Cary-Blair media or rectal swab.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (6)
University of Arizona
🇺🇸Tucson, Arizona, United States
St. Louis Children's Hospital
🇺🇸St. Louis, Missouri, United States
Vanderbilt University Medical Centre
🇺🇸Nashville, Tennessee, United States
Scott and White Memorial Hospital
🇺🇸Temple, Texas, United States
St. Joseph's Hospital
🇨🇦Hamilton, Ontario, Canada
Mount Sinai Hospital
🇨🇦Toronto, Ontario, Canada
University of Arizona🇺🇸Tucson, Arizona, United States
